|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tiseo M, Bordi P, Bortesi B, Boni L, Boni
C, Baldini E, Grossi F, Recchia F, Zanelli F, Fontanini G, et al:
Bio-FAST trial group: ERCC1/BRCA1 expression and gene polymorphisms
as prognostic and predictive factors in advanced NSCLC treated with
or without cisplatin. Br J Cancer. 108:1695–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caramori G, Casolari P, Cavallesco GN,
Giuffrè S, Adcock I and Papi A: Mechanisms involved in lung cancer
development in COPD. Int J Biochem Cell Biol. 43:1030–1044. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buttery RC, Rintoul RC and Sethi T: Small
cell lung cancer: The importance of the extracellular matrix. Int J
Biochem Cell Biol. 36:1154–1160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ettinger DS: Ten years of progress in
non-small cell lung cancer. J Natl Compr Cancer Netw. 10:292–295.
2012. View Article : Google Scholar
|
|
6
|
Su S, Hu Y, Ouyang W, Ma Z, Li Q, Li H,
Wang Y, Wang X, Li T, Li J, et al: Might radiation therapy in
addition to chemotherapy improve overall survival of patients with
non-oligometastatic Stage IV non-small cell lung cancer?: Secondary
analysis of two prospective studies. BMC Cancer. 16:9082016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saumet A and Lecellier CH: microRNAs and
personalized medicine: Evaluating their potential as cancer
biomarkers. Adv Exp Med Biol. 888:5–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O'Connell RM, Rao DS, Chaudhuri AA and
Baltimore D: Physiological and pathological roles for microRNAs in
the immune system. Nat Rev Immunol. 10:111–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan
M, Jeon YJ, Li B, Vicentini C, Peng Y, et al: MicroRNA-224 promotes
tumor progression in nonsmall cell lung cancer. Proc Natl Acad Sci
USA. 112:E4288–E4297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cui R, Kim T, Fassan M, Meng W, Sun HL,
Jeon YJ, Vicentini C, Tili E, Peng Y, Scarpa A, et al: MicroRNA-224
is implicated in lung cancer pathogenesis through targeting
caspase-3 and caspase-7. Oncotarget. 6:21802–21815. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carroll SB: Homeotic genes and the
evolution of arthropods and chordates. Nature. 376:479–485. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hedlund E, Karsten SL, Kudo L, Geschwind
DH and Carpenter EM: Identification of a Hoxd10-regulated
transcriptional network and combinatorial interactions with Hoxa10
during spinal cord development. J Neurosci Res. 75:307–319. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakayama I, Shibazaki M, Yashima-Abo A,
Miura F, Sugiyama T, Masuda T and Maesawa C: Loss of HOXD10
expression induced by upregulation of miR-10b accelerates the
migration and invasion activities of ovarian cancer cells. Int J
Oncol. 43:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Q, Ding C, Chen C, Zhang Z, Xiao H, Xie
F, Lei L, Chen Y, Mao B, Jiang M, et al: miR-224 promotion of cell
migration and invasion by targeting Homeobox D 10 gene in human
hepatocellular carcinoma. J Gastroenterol Hepatol. 29:835–842.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alonso DF, Ripoll GV, Garona J, Iannucci
NB and Gomez DE: Metastasis: Recent discoveries and novel
perioperative treatment strategies with particular interest in the
hemostatic compound desmopressin. Curr Pharm Biotechnol.
12:1974–1980. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
21
|
Hu K and Liang M: Upregulated microRNA-224
promotes ovarian cancer cell proliferation by targeting KLLN. In
Vitro Cell Dev Biol Anim. 53:149–156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu L, Zhang J, Guo X, Li Z and Zhang P:
MicroRNA-224 upregulation and AKT activation synergistically
predict poor prognosis in patients with hepatocellular carcinoma.
Cancer Epidemiol. 38:408–413. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Q, Wang G, Shan JL, Yang ZX, Wang HZ,
Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W, et al: MicroRNA-224 is
upregulated in HepG2 cells and involved in cellular migration and
invasion. J Gastroenterol Hepatol. 25:164–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Toh HC, Chow P, Chung AY, Meyers
DJ, Cole PA, Ooi LL and Lee CG: MicroRNA-224 is up-regulated in
hepatocellular carcinoma through epigenetic mechanisms. FASEB J.
26:3032–3041. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu S, Wang S, Geng S, Ma S, Liang Z and
Jiao B: Upregulation of microRNA-224 confers a poor prognosis in
glioma patients. Clin Transl Oncol. 15:569–574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Li CF, Ma LJ, Ding M and Zhang B:
MicroRNA-224 aggrevates tumor growth and progression by targeting
mTOR in gastric cancer. Int J Oncol. 49:1068–1080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu F, Liu Y, Shen J, Zhang G and Han J:
MicroRNA-224 inhibits proliferation and migration of breast cancer
cells by down-regulating Fizzled 5 expression. Oncotarget.
7:49130–49142. 2016.PubMed/NCBI
|
|
28
|
Goto Y, Nishikawa R, Kojima S, Chiyomaru
T, Enokida H, Inoguchi S, Kinoshita T, Fuse M, Sakamoto S, Nakagawa
M, et al: Tumour-suppressive microRNA-224 inhibits cancer cell
migration and invasion via targeting oncogenic TPD52 in prostate
cancer. FEBS Lett. 588:1973–1982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Barros E, Bueno Lima R, Ramão A,
Pinheiro DG, Alves CP, Kannen V, Jungbluth AA, de Araújo LF, Muys
BR, Fonseca AS, Plaça JR, et al: HOX genes: Potential candidates
for the progression of laryngeal squamous cell carcinoma. Tumour
Biol. 37:15087–15096. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vardhini NV, Rao PJ, Murthy PB and
Sudhakar G: HOXD10 expression in human breast cancer. Tumour Biol.
35:10855–10860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carrio M, Arderiu G, Myers C and Boudreau
NJ: Homeobox D10 induces phenotypic reversion of breast tumor cells
in a three-dimensional culture model. Cancer Res. 65:7177–7185.
2005. View Article : Google Scholar : PubMed/NCBI
|
